Order Parties: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v HEALIOS K.K, RIKEN, OSAKA UNIVERSITY Case number: UPC_CFI_75/2023 Order/Decision reference: ORD_552745/2023 Type of action(s): Procedural Order Court - Division: Court of First Instance - Munich (DE) Central Division - Section Language of Proceedings: English Date: 21 September, 2023 Headnotes: Rule 262.1(b) RoP requires a concrete and verifiable, legitimate reason for making available written pleadings and evidence upon a request by a member of the public. To be informed of the proceedings before the Unified Patent Court for the purposes of edu Keynotes: Rule 262.1(b) RoP request (rejected). Legitimate reason for access (no). No legal basis for access to letter for service.
Order Parties: Amgen, Inc. v. Sanofi-Aventis Deutschland GmbH Case number: UPC_CFI_1/2023 Order/Decision reference: ORD_550152/2023 Type of action(s): Procedural Order Court - Division: Court of First Instance - Munich (DE) Central Division - Section Language of Proceedings: English Date: 20 September, 2023 Headnotes: Rule 262.1(b) RoP requires a concrete and verifiable, legitimate reason for making available written pleadings and evidence upon a request by a member of the public. The wish from a natural person to form an opinion on the validity of a patent out of a pe Keynotes: Rule 262.1(b) RoP request (rejected). Legitimate reason for access (no).Rule 262.1(b) RoP request (rejected). Legitimate reason for access (no).
Order Parties: Amgen, Inc. v. Sanofi-Aventis Deutschland GmbH Case number: UPC_CFI_1/2023 Order/Decision reference: ORD_560432/2023 Type of action(s): Preliminary Objection Court - Division: Court of First Instance - Munich (DE) Central Division - Section Language of Proceedings: German Date: 24 August, 2023 Headnotes: Preliminary objection ex Rule 48/19.1(b) RoP. For determining competence of the divisions of the UPC in the context of Article 33.4 UPCA, second sentence, the central division needs to establish if a statement of claim to bring an infringement action has Keynotes: Preliminary objection, Rule 48/19.1(b) RoP, Article 33.4 UCPA, internal competence, competence central division (yes), date and time of lodging, Article 4.2 RoP, hard-copy lodging, Registry Rules
Order Parties: Sanofi-Aventis Deutschland GmbH v Amgen, Inc. Case number: UPC_CFI_1/2023 Order/Decision reference: ORD_536514/2023 Type of action(s): Revocation action Court - Division: Court of First Instance - Munich (DE) Central Division - Section Language of Proceedings: English Date: 29 June, 2023